167 related articles for article (PubMed ID: 36816432)
21. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
23. Natural product-inspired synthesis of coumarin-chalcone hybrids as potential anti-breast cancer agents.
Alhakamy NA; Saquib M; Sanobar ; Khan MF; Ansari WA; Arif DO; Irfan M; Khan MI; Hussain MK
Front Pharmacol; 2023; 14():1231450. PubMed ID: 37745072
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
25. Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations.
Eldehna WM; El Hassab MA; Abo-Ashour MF; Al-Warhi T; Elaasser MM; Safwat NA; Suliman H; Ahmed MF; Al-Rashood ST; Abdel-Aziz HA; El-Haggar R
Bioorg Chem; 2021 May; 110():104748. PubMed ID: 33684714
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
Luan S; Zhong H; Zhao X; Yang J; Jing Y; Liu D; Zhao L
Eur J Med Chem; 2017 Dec; 141():584-595. PubMed ID: 29102180
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
[TBL] [Abstract][Full Text] [Related]
28. Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells.
Nafie MS; Al-Majid AM; Ali M; Alayyaf AA; Haukka M; Ashraf S; Ul-Haq Z; El-Faham A; Barakat A
Front Chem; 2024; 12():1364378. PubMed ID: 38487783
[TBL] [Abstract][Full Text] [Related]
29. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids.
Grigoropoulou S; Manou D; Antoniou AI; Tsirogianni A; Siciliano C; Theocharis AD; Athanassopoulos CM
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684559
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis of benzimidazole tethered 3,4-dihydro-2H-benzo[e] [1, 3] oxazines as anticancer agents.
Gali S; Raghu D; Mallikanti V; Thumma V; Vaddiraju N
Mol Divers; 2023 May; ():. PubMed ID: 37233952
[TBL] [Abstract][Full Text] [Related]
32. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
33. 2-Alkyl-Substituted-4-Amino-Thieno[2,3-
Iliev I; Mavrova A; Yancheva D; Dimov S; Staneva G; Nesheva A; Tsoneva I; Nikolova B
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687177
[TBL] [Abstract][Full Text] [Related]
34. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
Eldehna WM; Abo-Ashour MF; Nocentini A; El-Haggar RS; Bua S; Bonardi A; Al-Rashood ST; Hassan GS; Gratteri P; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2019 Jan; 162():147-160. PubMed ID: 30445264
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
Eldehna WM; Almahli H; Al-Ansary GH; Ghabbour HA; Aly MH; Ismael OE; Al-Dhfyan A; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):600-613. PubMed ID: 28173708
[TBL] [Abstract][Full Text] [Related]
38. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
39. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of artemisinin-piperazine-furan ether hybrids and evaluation of in vitro cytotoxic activity.
Wei MX; Yu JY; Liu XX; Li XQ; Zhang MW; Yang PW; Yang JH
Eur J Med Chem; 2021 Apr; 215():113295. PubMed ID: 33636536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
